Determinants of the Response to BTK Degraders (BTKd) in Chronic Lymphocytic Leukemia
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
The aim of the REBELLE cohort - bio-collection is to collect samples from patients with Chronic Lymphocytic Leukemia candidates or those exposed to BTK degraders to evaluate the mechanisms of resistance to these new molecules. To do this, an additional blood or bone marrow sample to those planned in the context of patient care or a residual lymph node biopsy sample will be collected after signing consent.
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Pacjent z białaczką limfocytową, który ma być leczony nowymi lekami BTK lub już je przyjmuje
- •Pacjent, który wyraził świadomą zgodę na udział w badaniu
- •Pacjent objęty ubezpieczeniem zdrowotnym
✗ Disqualifies
- •Osoby niepełnoletnie
- •Dorośli pod opieką sądową
- •Osoby objęte specjalną ochroną prawną
Simplified criteria — AI translation
Trial details
- Minimum age
- 18 Years
- Last updated (source)
- July 8, 2026
- Sex
- No restrictions
Therapies / drugs in trial
Locations (14)
CHU de Angers
Angers, France
CHU de Bordeaux
Bordeaux, France
Institut Bergonié
Bordeaux, France
CHU de Clermont-Ferrand
Clermont-Ferrand, France
CHD Vendée
La Roche-sur-Yon, France
Centre Léon Bernard
Lyon, France
Institut Paoli-Calmettes (Marseille)
Marseille, France
CHU de Montpellier
Montpellier, France
CH Régional Universitaire de Nancy
Nancy, France
University Hospital
Nantes, France
Hôpital Avicenne (AP-HP)
Paris, France
Hôpital Universitaire Pitié Salpêtrière de Paris
Paris, France
CHU de Poitiers
Poitiers, France
Centre Henri-Becquerel de Rouen
Rouen, France
Trial contact
ANNE LOK, Dr
Benoit Tessoulin, Dr
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 7/9/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.